Advertisement

Updated Testing Guidelines Make More Women Eligible for Herceptin, Yet Benefit Uncertain

Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study.

 Science Daily

click me